Stay updated on Pembrolizumab Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Skin Cancer Clinical Trial page
- Check4 days agoChange DetectedThe site's software version label was updated from v3.6.4 to v3.6.5, indicating a new build of the underlying platform. This change represents an internal update rather than a modification to page content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page shows a revision update from v3.6.3 to v3.6.4, indicating an incremental software release. It represents a backend or UI improvement rather than any changes to study text or results.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedAdded the page revision tag v3.6.3 and removed the previous v3.6.0, updating the page's version reference in the metadata.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now reflects that recruitment has ended and introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment heading styling and records a revision from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check69 days agoChange DetectedRevision: v3.5.5 appears, replacing the prior v3.5.4. This indicates a minor site update or patch rather than changes to the study details or content.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision tag on the page changed from v3.5.3 to v3.5.4, indicating a small update to the page’s revision history or documentation. This update does not alter the study details or core content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.